In vitro effects of 0 to 120 Grays of irradiation on bone viability and release of growth factors

BMC Oral Health. 2016 Jul 4;17(1):4. doi: 10.1186/s12903-016-0241-9.

Abstract

Background: High dose radiation therapy is commonly used in maxillofacial surgeries to treat a number of head and neck tumors. Despite its widespread use, little information is available regarding the effects of irradiation on bone cell viability and release of growth factors following dose-dependent irradiation.

Methods: Bone samples were collected from porcine mandibular cortical bone and irradiated at doses of 0, 7.5, 15, 30, 60 and 120 Grays. Thereafter, cell viability was quantified, and the release of growth factors including TGFβ1, BMP2, VEGF, IL1β and RANKL were investigated over time.

Results: It was observed that at only 7.5Gy of irradiation, over 85 % of cells were non-vital and by 60 Gy, all cells underwent apoptosis. Furthermore, over a 7-fold decrease in VEGF and a 2-fold decrease in TGFβ1 were observed following irradiation at all tested doses. Little change was observed for BMP2 and IL1β whereas RANKL was significantly increased for all irradiated samples.

Conclusions: These results demonstrate the pronounced effects of irradiation on bone-cell vitality and subsequent release of growth factors. Interestingly, the largest observed change in gene expression was the 7-fold decrease in VEGF protein following irradiation. Future research aimed at improving our understanding of bone following irradiation is necessary to further improve future clinical treatments.

Keywords: Bone cell death; Bone chips; Grays; Growth factor release; Irradiation.

MeSH terms

  • Animals
  • Cell Survival*
  • Head and Neck Neoplasms / radiotherapy*
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Interleukin-1beta
  • Mandible / cytology*
  • Mandible / metabolism
  • Swine

Substances

  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1beta